ID

31681

Descripción

COMPERA / COMPERA-KIDS; ODM derived from: https://clinicaltrials.gov/show/NCT01347216

Link

https://clinicaltrials.gov/show/NCT01347216

Palabras clave

Versiones (1)
  1. 20/9/18 20/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Pulmonary Arterial Hypertension (PAH) NCT01347216

Inglés

Eligibility Pulmonary Arterial Hypertension (PAH) NCT01347216

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
all age groups (amendment dated 1 june 2013)
Descripción

Age Groups All

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027362
UMLS CUI [1,2]
C0444868
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
pulmonary hypertension (ph) of either
Descripción

Pulmonary Hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020542
pah: idiopathic form (ipah) or
Descripción

Pulmonary arterial hypertension | Idiopathic pulmonary arterial hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C3203102
pah associated with connective tissue diseases (pah-ctd), with congenital heart defects (pah-chd), with hiv infection (pah-hiv), or the portopulmonary form
Descripción

Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Pulmonary arterial hypertension associated with HIV infection | Portopulmonary hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3697982
UMLS CUI [2]
C3697119
UMLS CUI [3]
C3697673
UMLS CUI [4]
C1868851
chronic thromboembolic ph (cteph)
Descripción

Chronic thromboembolic pulmonary hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2363973
ph in left heart diseases (with isolated diastolic dysfunction; with systolic dysfunction, other)
Descripción

Pulmonary hypertension due to left heart disease | Pulmonary hypertension due to left heart disease Associated with Isolated Diastolic dysfunction | Pulmonary hypertension due to left heart disease Associated with Systolic dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3532326
UMLS CUI [2,1]
C3532326
UMLS CUI [2,2]
C0332281
UMLS CUI [2,3]
C0520863
UMLS CUI [2,4]
C0205409
UMLS CUI [3,1]
C3532326
UMLS CUI [3,2]
C0332281
UMLS CUI [3,3]
C0749225
ph in pulmonary disease (chronic obstructive pulmonary disease; interstitial fibrosis, etc.)
Descripción

Pulmonary Hypertension Due to Lung disease | Pulmonary hypertension due to chronic obstructive pulmonary disease | Pulmonary Hypertension Due to Interstitial fibrosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0024115
UMLS CUI [2]
C3696884
UMLS CUI [3,1]
C0020542
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C3887486
"relative ph" in chd after cavopulmonary anastomosis or fontan-type surgery, even without the classical pulmonary pressure criteria of ph.
Descripción

Pulmonary Hypertension Due to Congenital heart disease | Status post Cavopulmonary anastomosis | Status post Fontan type operation |

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0152021
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0242838
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0190010
newly initiated (i.e. a maximum of 3 months before documentation for the first time) therapy with era, pde-5 inhibitors or prostacyclins in mono- or combination therapy.
Descripción

Therapeutic procedure Initiation | Endothelin receptor antagonist | Phosphodiesterase 5 inhibitor | Prostacyclin | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1704686
UMLS CUI [2]
C1134681
UMLS CUI [3]
C1318700
UMLS CUI [4]
C0033567
UMLS CUI [5]
C0009429
exceptions: pah-chd patients can be included on maintenance or newly initiated pah therapy (3-month rule dose not apply).
Descripción

Exception | Maintenance therapy Including Pulmonary arterial hypertension associated with congenital heart disease | Therapeutic procedure Initiation Including Pulmonary arterial hypertension associated with congenital heart disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1705847
UMLS CUI [2,1]
C0677908
UMLS CUI [2,2]
C0332257
UMLS CUI [2,3]
C3697119
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1704686
UMLS CUI [3,3]
C0332257
UMLS CUI [3,4]
C3697119
pah-chd patients with severe pulmonary vascular disease (e.g. eisenmenger physiology) irrespective of treatment with any pah drugs are eligible for inclusion, too.
Descripción

Pulmonary arterial hypertension with congenital heart disease Associated with Vascular disease of lung Severe | Eisenmenger Complex

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3697119
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0543826
UMLS CUI [1,4]
C0205082
UMLS CUI [2]
C0013743
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients on maintenance therapy, i.e. previous treatment with any era/
Descripción

Maintenance therapy | Prior Therapy Endothelin receptor antagonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677908
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C1134681
pde-v-inhibitor/prostacyclin/sgc stimulator drug longer than 3 months before documentation for the first time (exception: pah-chd patients).
Descripción

Phosphodiesterase 5 inhibitor | prostacyclin | soluble guanylyl cyclase | Exception Pulmonary arterial hypertension associated with congenital heart disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1318700
UMLS CUI [2]
C0033567
UMLS CUI [3]
C1097411
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C3697119
Volver a la parte superior de la página

Similar models

Eligibility Pulmonary Arterial Hypertension (PAH) NCT01347216

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age Groups All
Item
all age groups (amendment dated 1 june 2013)
boolean
C0027362 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Pulmonary Hypertension
Item
pulmonary hypertension (ph) of either
boolean
C0020542 (UMLS CUI [1])
Pulmonary arterial hypertension | Idiopathic pulmonary arterial hypertension
Item
pah: idiopathic form (ipah) or
boolean
C2973725 (UMLS CUI [1])
C3203102 (UMLS CUI [2])
Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Pulmonary arterial hypertension associated with HIV infection | Portopulmonary hypertension
Item
pah associated with connective tissue diseases (pah-ctd), with congenital heart defects (pah-chd), with hiv infection (pah-hiv), or the portopulmonary form
boolean
C3697982 (UMLS CUI [1])
C3697119 (UMLS CUI [2])
C3697673 (UMLS CUI [3])
C1868851 (UMLS CUI [4])
Chronic thromboembolic pulmonary hypertension
Item
chronic thromboembolic ph (cteph)
boolean
C2363973 (UMLS CUI [1])
Pulmonary hypertension due to left heart disease | Pulmonary hypertension due to left heart disease Associated with Isolated Diastolic dysfunction | Pulmonary hypertension due to left heart disease Associated with Systolic dysfunction
Item
ph in left heart diseases (with isolated diastolic dysfunction; with systolic dysfunction, other)
boolean
C3532326 (UMLS CUI [1])
C3532326 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0520863 (UMLS CUI [2,3])
C0205409 (UMLS CUI [2,4])
C3532326 (UMLS CUI [3,1])
C0332281 (UMLS CUI [3,2])
C0749225 (UMLS CUI [3,3])
Pulmonary Hypertension Due to Lung disease | Pulmonary hypertension due to chronic obstructive pulmonary disease | Pulmonary Hypertension Due to Interstitial fibrosis
Item
ph in pulmonary disease (chronic obstructive pulmonary disease; interstitial fibrosis, etc.)
boolean
C0020542 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,3])
C3696884 (UMLS CUI [2])
C0020542 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C3887486 (UMLS CUI [3,3])
Pulmonary Hypertension Due to Congenital heart disease | Status post Cavopulmonary anastomosis | Status post Fontan type operation |
Item
"relative ph" in chd after cavopulmonary anastomosis or fontan-type surgery, even without the classical pulmonary pressure criteria of ph.
boolean
C0020542 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0152021 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0242838 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0190010 (UMLS CUI [3,2])
Therapeutic procedure Initiation | Endothelin receptor antagonist | Phosphodiesterase 5 inhibitor | Prostacyclin | Combined Modality Therapy
Item
newly initiated (i.e. a maximum of 3 months before documentation for the first time) therapy with era, pde-5 inhibitors or prostacyclins in mono- or combination therapy.
boolean
C0087111 (UMLS CUI [1,1])
C1704686 (UMLS CUI [1,2])
C1134681 (UMLS CUI [2])
C1318700 (UMLS CUI [3])
C0033567 (UMLS CUI [4])
C0009429 (UMLS CUI [5])
Exception | Maintenance therapy Including Pulmonary arterial hypertension associated with congenital heart disease | Therapeutic procedure Initiation Including Pulmonary arterial hypertension associated with congenital heart disease
Item
exceptions: pah-chd patients can be included on maintenance or newly initiated pah therapy (3-month rule dose not apply).
boolean
C1705847 (UMLS CUI [1])
C0677908 (UMLS CUI [2,1])
C0332257 (UMLS CUI [2,2])
C3697119 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
C0332257 (UMLS CUI [3,3])
C3697119 (UMLS CUI [3,4])
Pulmonary arterial hypertension with congenital heart disease Associated with Vascular disease of lung Severe | Eisenmenger Complex
Item
pah-chd patients with severe pulmonary vascular disease (e.g. eisenmenger physiology) irrespective of treatment with any pah drugs are eligible for inclusion, too.
boolean
C3697119 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0543826 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0013743 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Maintenance therapy | Prior Therapy Endothelin receptor antagonist
Item
patients on maintenance therapy, i.e. previous treatment with any era/
boolean
C0677908 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C1134681 (UMLS CUI [2,2])
Phosphodiesterase 5 inhibitor | prostacyclin | soluble guanylyl cyclase | Exception Pulmonary arterial hypertension associated with congenital heart disease
Item
pde-v-inhibitor/prostacyclin/sgc stimulator drug longer than 3 months before documentation for the first time (exception: pah-chd patients).
boolean
C1318700 (UMLS CUI [1])
C0033567 (UMLS CUI [2])
C1097411 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C3697119 (UMLS CUI [4,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial